Precigen (PGEN) Net Equity Issued and Repurchased (2012 - 2025)

Precigen (PGEN) has reported Net Equity Issued and Repurchased for 8 consecutive years, with -$355000.0 the latest figure, recorded in Q1 2025.

• In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$355000.0; the TTM figure through Dec 2025 stood at -$355000.0 (down 101.14% YoY), while the FY2025 annual figure was -$355000.0, down 101.14% from the prior year.
• Net Equity Issued and Repurchased climbed to -$355000.0 in Q1 2025 per PGEN's latest filing, from -$596000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $121.0 million in Q1 2021 and bottomed at -$693000.0 in Q2 2023.
• Historically, Net Equity Issued and Repurchased has averaged $37.5 million across 4 years, with a median of $15.7 million in 2024.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 245.84% in 2021 and fell as far as 245.84% in 2021.
• Precigen's Net Equity Issued and Repurchased stood at $121.0 million in 2021, then slumped by 100.57% to -$693000.0 in 2023, then increased by 14.0% to -$596000.0 in 2024, then soared by 40.44% to -$355000.0 in 2025.
• Business Quant data shows PGEN's Net Equity Issued and Repurchased at -$355000.0 in Q1 2025, -$596000.0 in Q4 2024, and $31.8 million in Q3 2024.